Cargando…

In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals

The aim of this study is to identify potential drug-like molecules against SARS-CoV-2 virus among the natural antiviral compounds published in the Encyclopedia of Traditional Chinese Medicine. To test inhibition capability of these compounds first, we docked them with Spike protein, angiotensin-conv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Şimşek, Yusuf, Baran, Sahra Setenay, Aslım, Belma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479391/ https://www.ncbi.nlm.nih.gov/pubmed/34607208 http://dx.doi.org/10.1016/j.jmgm.2021.108038

Ejemplares similares

Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry
por: Carvalhal, Francisca, et al.
Publicado: (2023)

Antiviral lectins: Selective inhibitors of viral entry
por: Mitchell, Carter A., et al.
Publicado: (2017)

Antiviral Activity of Two Marine Carotenoids against SARS-CoV-2 Virus Entry In Silico and In Vitro
por: Yim, Sung-Kun, et al.
Publicado: (2021)

Screening of Natural Products Inhibitors of SARS-CoV-2 Entry
por: González-Maldonado, Pamela, et al.
Publicado: (2022)

Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
por: Choudhary, Shweta, et al.
Publicado: (2020)

Gut-lung axis and dysbiosis in COVID-19
por: AKTAS, Busra, et al.
Publicado: (2020)

Characterization of lactic acid bacteria derived exopolysaccharides for use as a defined neuroprotective agent against amyloid beta(1–42)-induced apoptosis in SH-SY5Y cells
por: Sirin, Seda, et al.
Publicado: (2020)

Neuropathy in COVID-19 associated with dysbiosis-related inflammation
por: AKTAS, Busra, et al.
Publicado: (2021)

Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach
por: Ambrose, Jenifer Mallavarpu, et al.
Publicado: (2022)

SARS-CoV-2 cell entry and targeted antiviral development
por: Chen, Zinuo, et al.
Publicado: (2021)

The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling
por: Pitsillou, Eleni, et al.
Publicado: (2022)

Identification of potent small molecule inhibitors of SARS-CoV-2 entry
por: Mediouni, Sonia, et al.
Publicado: (2022)

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
por: Han, Dong P., et al.
Publicado: (2006)

Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products
por: He, Chang-Long, et al.
Publicado: (2021)

Inhibition of SARS-CoV2 viral infection with natural antiviral plants constituents: An in-silico approach
por: Das, Kuntal, et al.
Publicado: (2023)

Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach
por: Singh, Swati, et al.
Publicado: (2022)

In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection
por: Vivek-Ananth, R.P., et al.
Publicado: (2020)

In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack
por: Hussein, Mouraya, et al.
Publicado: (2022)

Identification of SARS-CoV-2 entry inhibitors among already approved drugs
por: Yang, Li, et al.
Publicado: (2020)

Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
por: Lee, Richard Kuan-Lin, et al.
Publicado: (2022)

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
por: Groß, Rüdiger, et al.
Publicado: (2022)

In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10
por: Eissa, Ibrahim H., et al.
Publicado: (2021)

Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry
por: Zhang, Dingqi, et al.
Publicado: (2021)

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Targeting SARS‐CoV‐2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound
por: Eid, Jehane Ibrahim, et al.
Publicado: (2021)

Antiproliferative, neurotoxic, genotoxic and mutagenic effects of toxic cyanobacterial extracts
por: Andeden, Enver Ersoy, et al.
Publicado: (2018)

The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19
por: Sirin, Seda, et al.
Publicado: (2022)

In silico evidence of beauvericin antiviral activity against SARS-CoV-2
por: Al Khoury, Charbel, et al.
Publicado: (2022)

Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors
por: Huang, Li, et al.
Publicado: (2022)

An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses
por: Mayor, Jennifer, et al.
Publicado: (2021)

In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts
por: Shadrack, Daniel M., et al.
Publicado: (2021)

Natural photosensitizers potentiate the targeted antimicrobial photodynamic therapy as the Monkeypox virus entry inhibitors: An in silico approach
por: Pourhajibagher, Maryam, et al.
Publicado: (2023)

Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay
por: Zhou, Yanchen, et al.
Publicado: (2011)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
por: Hariyono, Pandu, et al.
Publicado: (2022)

Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infection
por: Singh, Satyendra, et al.
Publicado: (2022)

The relationship between the structural characteristics of lactobacilli-EPS and its ability to induce apoptosis in colon cancer cells in vitro
por: Tukenmez, Ummugulsum, et al.
Publicado: (2019)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

Peptide and peptide-based inhibitors of SARS-CoV-2 entry
por: Schütz, Desiree, et al.
Publicado: (2020)

SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids
por: Gyebi, Gideon A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i9k9bqn1dlj5142etf2kmdf7ou